Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Net Income of $1.3 million and Adjusted EBITDA of $12.0 million Gross margin expansion from promotional reset and SG&A leverage from cost control Net liquidity of $73.3 million with inventory...
-
Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The "Fitness Mirrors Market - Focused Insights 2025-2030" report has been added to ResearchAndMarkets.com's offering.The Fitness Mirrors Market was valued...
-
Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American College of Cardiology New...
-
Only transparency, accountability, and cooperation through open dialogue can save CERN from the misuse of trust, funds, resulting in the waste of billions
-
Dallas, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- The North Texas Food Bank (NTFB) celebrated its 20th Annual Agency Partner Summit at the Renaissance Hotel in Richardson, recognizing local hunger...
-
TARRYTOWN, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the target action...
-
Miami, Fla., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential businesses,...
-
Miami, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential businesses,...
-
Leading international experts to support clinical development of BellaSeno´s pioneering resorbable breast implantsPivotal clinical trial to be initiated shortly Leipzig, Germany / Brisbane,...
-
Generated record Q2 Contribution ex-TAC, programmatic revenue and CTV revenue Increased Adjusted EBITDA Margin to 34% of Contribution ex-TAC from 32% in Q2 2024 Renewed and expanded strategic...